These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6864378)

  • 1. Tobramycin sulfate elimination in premature infants.
    Arbeter AM; Saccar CL; Eisner S; Sarni E; Yaffe SJ
    J Pediatr; 1983 Jul; 103(1):131-5. PubMed ID: 6864378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobramycin pharmacokinetics in very low birth weight infants.
    Nahata MC; Powell DA; Durrell DE; Miller MA
    Br J Clin Pharmacol; 1986 Mar; 21(3):325-7. PubMed ID: 3964533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gestational age and birth weight on tobramycin kinetics in newborn infants.
    Nahata MC; Powell DA; Durrell DE; Miller MC; Glazer JP
    J Antimicrob Chemother; 1984 Jul; 14(1):59-65. PubMed ID: 6480541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobramycin kinetics in newborn infants.
    Nahata MC; Powell DA; Gregoire RP; McClead RE; Menke JA; Bickers RG; Glazer JP
    J Pediatr; 1983 Jul; 103(1):136-8. PubMed ID: 6864379
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacology of tobramycin in infants.
    Bratlid D; Fuglesang JE
    Scand J Infect Dis; 1979; 11(1):73-6. PubMed ID: 419372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapatient variation in tobramycin kinetics in low birth weight infants during first postnatal week.
    Nahata MC; Powell DA; Durrell DE; Miller MA; Glazer JP
    Eur J Clin Pharmacol; 1984; 26(5):647-9. PubMed ID: 6468485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tobramycin in the newborn.
    Yoshioka H; Takimoto M; Fujita K; Maruyama S
    Infection; 1979; 7(4):180-2. PubMed ID: 511335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematically individualizing tobramycin dosage regimens.
    Cipolle RJ; Seifert RD; Zaske DE; Strate RG
    J Clin Pharmacol; 1980 Oct; 20(10):570-80. PubMed ID: 7440765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.
    Bauer LA; Piecoro JJ; Wilson HD; Blouin RA
    Clin Pharm; 1983; 2(3):262-4. PubMed ID: 6883955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobramycin pharmacokinetics in premature identical twins during newborn period.
    Nahata MC; Durrell DE; Miller MA
    Dev Pharmacol Ther; 1986; 9(3):178-82. PubMed ID: 3709337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin disposition and effect on development of renal function in the very low birth weight infant.
    Landers S; Berry PL; Kearns GL; Kaplan SL; Rudolph AJ
    Dev Pharmacol Ther; 1984; 7(5):285-302. PubMed ID: 6383749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental pattern of gentamicin kinetics in very low birth weight (VLBW) sick infants.
    Kildoo C; Modanlou HD; Komatsu G; Harralson A; Hodding J
    Dev Pharmacol Ther; 1984; 7(6):345-56. PubMed ID: 6518943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenously administered tobramycin in normal volunteers and in renal-impaired and hemodialyzed patients.
    Péchère JC; Dugal R
    J Infect Dis; 1976 Aug; 134 Suppl():S118-24. PubMed ID: 972269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of age on tobramycin pharmacokinetics in patients with normal renal function.
    Bauer LA; Blouin RA
    Antimicrob Agents Chemother; 1981 Nov; 20(5):587-9. PubMed ID: 7325627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tobramycin levels in low- and very low-birthweight infants.
    Cordero L; Arwood L; Hann C; Visconti J
    Am J Perinatol; 1984 Apr; 1(3):242-6. PubMed ID: 6525212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimalisation of netilmicin dosage based on therapeutic drug monitoring during the first days of life in very preterm neonates (gestational age 23-32 weeks)].
    Rutkowska M; Kamińska E; Piekarczyk A; Nowicka K; Polak K; Nowakowska-Szyrwińska E; Szamotulska K
    Med Wieku Rozwoj; 2009; 13(4):252-9. PubMed ID: 20081273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified model for adjustment of gentamicin dosage in newborn infants.
    Herngren L; Broberger U; Wretlind B
    Acta Paediatr Scand; 1986 Mar; 75(2):198-204. PubMed ID: 3962654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.